Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry

Loss-of-function mutations in PALB2 are associated with an increased risk of breast cancer, with recent data showing that female breast cancer risks for PALB2 mutation carriers are comparable in magnitude to those for BRCA2 mutation carriers. This study applied targeted massively parallel sequencing...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Breast Cancer Res Treat
Egile Nagusiak: Nguyen-Dumont, Tú, Hammet, Fleur, Mahmoodi, Maryam, Tsimiklis, Helen, Teo, Zhi L., Li, Roger, Pope, Bernard J., Terry, Mary Beth, Buys, Saundra S., Daly, Mary, Hopper, John L., Winship, Ingrid, Goldgar, David E., Park, Daniel J., Southey, Melissa C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542063/
https://ncbi.nlm.nih.gov/pubmed/25575445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3260-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak